Weak grip, poor balance, and slow chair stands all show up in studies as markers of worse health later. The largest dataset is grip strength. In the PURE cohort of 139,691 adults in 17 countries, a lower grip tracked with a higher risk of death, and it did so more tightly than systolic blood pressure did. We think these three tests are worth doing at home, with one rule attached: they are dashboards, not verdicts. Every study below is observational, so none of them shows that raising your score extends your life.
Here is how to run each test, how to read the number, and where the evidence runs out.
Grip strength is a read on the whole body 🧬
Your hand is not the point. A dynamometer (a handheld squeeze gauge) gives a quick, standardized read on overall muscle strength and nerve-to-muscle signaling. In an accompanying commentary in The Lancet, Avan Aihie Sayer and Thomas Kirkwood suggested that grip may work as a biomarker of aging across the life course, partly because few diseases attack hand muscle alone.
The PURE analysis followed adults aged 35 to 70 for a median of 4 years, during which 3,379 people (2%) died. Every 5 kg lower grip went with a 16% higher risk of death from any cause, 17% higher cardiovascular death, 7% higher heart attack risk, and 9% higher stroke risk. Notably, grip did not predict diabetes, falls, or fractures. PURE received partial funding from unrestricted pharmaceutical grants, which the authors disclosed.
The brain link is newer. In the UK Biobank cohort of 466,788 adults, the weakest-grip fifth had 72% higher dementia risk than the strongest fifth over roughly nine years of follow-up (public funders, including the Wellcome Trust and Medical Research Council). A 2026 meta-analysis of prospective cohorts in people 45 and older put the risk of cognitive decline about 19% lower with stronger baseline grip. Again, association, not proof.
How to test and read it:
Device: a hand dynamometer. Squeezing a rubber ball tells you nothing.
Method: sit with your elbow bent at about 90 degrees, squeeze hard, and record the best of a few tries per hand. Use the same device and posture each time.
Low line: the European sarcopenia group (EWGSOP2) flags under 27 kg for men and 16 kg for women as probable muscle weakness.
Caveat: that line is disputed. A Brazilian team argued for 36 kg and 23 kg as better mortality predictors, and one study of 1,825 older adults found low grip in 12.2% using 27/16 but 37.5% using 35/20.
We would treat the 27/16 line as “clearly low” and watch your trend more than any single reading. Do you know your number right now?
One-leg balance for 10 seconds 🧠
Standing on one foot asks your inner ear, your joint sensors, your eyes, your hip and ankle muscles, and your brain to cooperate at once. Slippage in any of them shows up as wobble.
A 2022 British Journal of Sports Medicine analysis from the CLINIMEX cohort tested 1,702 adults aged 51 to 75 (average 61, 68% men) on a 10-second one-legged stance. Participants went barefoot, placed the free foot on the back of the other lower leg, kept arms at their sides, and got up to three attempts. About 20% failed. Failure climbed fast with age: 4.7% at 51 to 55, 36.8% at 66 to 70, and 53.6% at 71 to 75.
Over a median of about 7 years of follow-up, 17.5% of those who failed had died versus 4.6% of those who passed. After adjusting for age, sex, BMI, and conditions including heart disease and diabetes, failing carried an 84% higher risk of death from any cause. Failers were also three times as likely to have type 2 diabetes.
The limits matter. It was a single-clinic, observational cohort, mostly white and higher-income Brazilians, and the authors warned against extrapolating to other groups. No trial has shown that training balance changes mortality.
Setup: stand near a counter or wall so you can catch yourself.
Pass: 10 seconds on each leg, no hopping or grabbing.
Fail on one side only: worth mentioning to a clinician, since a one-sided problem is a different story from general decline.
Retest: monthly is plenty. Balance changes slowly.
Try it barefoot before you read on. Did both legs pass?
Sit-to-stand measures leg power and fall risk
Rising from a chair takes quadriceps and glute strength, speed, and balance in one move. That is why physical therapists have used it for decades.
The version to use is the CDC’s STEADI 30-second chair stand: a straight-backed chair about 17 inches high pushed against a wall, arms crossed over your chest, feet flat. Count full stands in 30 seconds. If you are more than halfway up when time ends, it counts. If you must use your arms, the score is zero.
CDC below-average scores (taken from norms by Rikli and Jones in 1999, so they reflect community-dwelling older adults) look like this:
Ages 60 to 64: under 14 for men, under 12 for women
Ages 65 to 69: under 12 for men, under 11 for women
Ages 70 to 74: under 12 for men, under 10 for women
Ages 75 to 79: under 11 for men, under 10 for women
Those cutoffs flag fall risk, which is what the test was built for. The mortality link is murkier. A Toledo Study for Healthy Aging analysis of 1,876 adults aged 65 and older used an equation to turn chair-stand results into estimated muscle power. Men with low relative power had a 57% higher risk of death, and the association in women was stronger. Women with low power were also more than three times as likely to have had a hip fracture. Because the estimate uses an equation, your raw count is not directly comparable. For the full intelligence picture behind developments like this one, LongevityHub Pro has you covered. Meanwhile, the floor “sitting-rising” test that went viral from a 2012 study in people 51 to 80 has drawn pushback, with NCOA’s Jennifer Tripkin telling Fortune it is not a true mortality predictor.
What to do with your three numbers
Write them down today. A score matters less than its direction over the next year.
The good news is that these measures respond to training. A 2025 network meta-analysis in Frontiers in Physiology pooled 13 randomized trials with 711 older adults (average age 68, about 80% women, all with sarcopenia) and found that resistance training improved grip strength. Its best-fitting dose was about three sessions a week for roughly 19 weeks. That is a population with a specific condition, so results may differ for you.
What is still unknown is whether raising your score lowers your risk of dying. Darryl Leong, the PURE lead author, said as much when the results came out: more work is needed to know if building strength reduces risk.
Retest all three in 8 weeks under identical conditions.
See a clinician if you have fallen, feel dizzy, or notice a sudden drop in one hand or leg.
Fix the weakest link first. Low grip and low chair stands usually mean the same thing: you need more resistance training.
Skip the panic. One bad day is noise, and three bad tests across months is a signal worth acting on.
Which of the three do you think will be your weakest, and what is your plan for the next eight weeks?


